[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2324304A2 - Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament - Google Patents

Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Info

Publication number
FR2324304A2
FR2324304A2 FR7528939A FR7528939A FR2324304A2 FR 2324304 A2 FR2324304 A2 FR 2324304A2 FR 7528939 A FR7528939 A FR 7528939A FR 7528939 A FR7528939 A FR 7528939A FR 2324304 A2 FR2324304 A2 FR 2324304A2
Authority
FR
France
Prior art keywords
quinoline
hydroxy
thiazolyl
prepd
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7528939A
Other languages
English (en)
Other versions
FR2324304B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7528939A priority Critical patent/FR2324304A2/fr
Publication of FR2324304A2 publication Critical patent/FR2324304A2/fr
Application granted granted Critical
Publication of FR2324304B2 publication Critical patent/FR2324304B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7528939A 1975-09-22 1975-09-22 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament Granted FR2324304A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7528939A FR2324304A2 (fr) 1975-09-22 1975-09-22 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7528939A FR2324304A2 (fr) 1975-09-22 1975-09-22 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
FR2324304A2 true FR2324304A2 (fr) 1977-04-15
FR2324304B2 FR2324304B2 (fr) 1978-09-01

Family

ID=9160268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7528939A Granted FR2324304A2 (fr) 1975-09-22 1975-09-22 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Country Status (1)

Country Link
FR (1) FR2324304A2 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012639A2 (fr) * 1978-12-08 1980-06-25 Roussel-Uclaf Nouveaux dérivés de l'acide 3-quinoléine carboxylique, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant
FR2507602A1 (fr) * 1981-06-12 1982-12-17 Roussel Uclaf Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
EP0067772A1 (fr) * 1981-06-12 1982-12-22 Roussel-Uclaf Nouveaux dérivés du N-dihydrothiazolyl 3-quinoléine carboxamide, leurs sels, leur procédé de préparation, leur application à titre de médicaments et les compositions les renfermant
EP0317991A2 (fr) * 1987-11-27 1989-05-31 Hoechst-Roussel Pharmaceuticals Incorporated 3-Carboxamides de la 1-arylquinoléine et de la 1-arylisoquinoléine, un procédé de leur préparation et leur utilisation comme médicaments
US7495103B2 (en) 2004-06-24 2009-02-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US9139530B2 (en) 2005-12-28 2015-09-22 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
US9751839B2 (en) 2009-03-20 2017-09-05 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US10272046B2 (en) 2012-02-27 2019-04-30 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US10646481B2 (en) 2008-08-13 2020-05-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218896A1 (fr) * 1973-02-26 1974-09-20 Allen & Hanburys Ltd

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218896A1 (fr) * 1973-02-26 1974-09-20 Allen & Hanburys Ltd

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012639A2 (fr) * 1978-12-08 1980-06-25 Roussel-Uclaf Nouveaux dérivés de l'acide 3-quinoléine carboxylique, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant
EP0012639A3 (en) * 1978-12-08 1980-11-12 Roussel-Uclaf Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them
EP0049555A1 (fr) * 1978-12-08 1982-04-14 Roussel-Uclaf Nouveaux dérivés de l'acide 2-trifluorométhyl-4-hydroxy-3-quinoline carboxylique et leur procédé de préparation
FR2507602A1 (fr) * 1981-06-12 1982-12-17 Roussel Uclaf Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
EP0067772A1 (fr) * 1981-06-12 1982-12-22 Roussel-Uclaf Nouveaux dérivés du N-dihydrothiazolyl 3-quinoléine carboxamide, leurs sels, leur procédé de préparation, leur application à titre de médicaments et les compositions les renfermant
EP0317991A2 (fr) * 1987-11-27 1989-05-31 Hoechst-Roussel Pharmaceuticals Incorporated 3-Carboxamides de la 1-arylquinoléine et de la 1-arylisoquinoléine, un procédé de leur préparation et leur utilisation comme médicaments
EP0317991A3 (fr) * 1987-11-27 1990-11-07 Hoechst-Roussel Pharmaceuticals Incorporated 3-Carboxamides de la 1-arylquinoléine et de la 1-arylisoquinoléine, un procédé de leur préparation et leur utilisation comme médicaments
US8629162B2 (en) 2004-06-24 2014-01-14 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8101767B2 (en) 2004-06-24 2012-01-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8324242B2 (en) 2004-06-24 2012-12-04 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8614327B2 (en) 2004-06-24 2013-12-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US10662192B2 (en) 2004-06-24 2020-05-26 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8741925B2 (en) 2004-06-24 2014-06-03 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US7495103B2 (en) 2004-06-24 2009-02-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US9090619B2 (en) 2004-06-24 2015-07-28 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US9139530B2 (en) 2005-12-28 2015-09-22 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9670163B2 (en) 2005-12-28 2017-06-06 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9931334B2 (en) 2005-12-28 2018-04-03 Vertex Pharmaceuticals Incorporated Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US11291662B2 (en) 2005-12-28 2022-04-05 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US10537565B2 (en) 2005-12-28 2020-01-21 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US11564916B2 (en) 2008-08-13 2023-01-31 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US10646481B2 (en) 2008-08-13 2020-05-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US9751839B2 (en) 2009-03-20 2017-09-05 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US11147770B2 (en) 2012-02-27 2021-10-19 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US10272046B2 (en) 2012-02-27 2019-04-30 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US11752106B2 (en) 2012-02-27 2023-09-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Also Published As

Publication number Publication date
FR2324304B2 (fr) 1978-09-01

Similar Documents

Publication Publication Date Title
FR2324304A2 (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
LV10575A (lv) Izoksazoi-4-karbonskabes amids un hidroksialkiliden-cianetikskabes amids sos savienojumus saturosi astniecibas lidzekli un to pielietojums
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
GB1133013A (en) Process of preparing amides
GB1224546A (en) 5-(nitrofurfurylidine) thiazoline- and thiazolidine 4-ones
SE429964B (sv) Forfarande for framstellning av a-aminosyreamid
FR2340092A2 (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
GB1434425A (en) Dioxamates and the manufacture thereof
PT64980A (en) Process for preparing carboxylic acid amides with hypolipaemic effect,application of the same for preparing pharmaceutical compositions with hypolipaemic effect and application of said pharmaceutical compositions for the treatment of hyperlipaemia
ES392093A1 (es) Procedimiento para la preparacion de derivados del amino-2 cloro-5-tiazol.
ES426436A1 (es) Procedimiento para la obtencion de derivados de la 3,3-bis (4-hidroxifenil)-2-indolinona.
GB962734A (en) A process for the production of acetoacetic acid amides
GB1050737A (fr)
GB1447521A (en) Naphthalimide-4,5-dicarboxylic acids
GB986359A (en) 3-substituted hydantoin derivatives
GB1252580A (fr)
FR1282893A (fr) Procédé d'obtention des acides nicotinique et isonicotinique à partir de bases de pyridine ainsi que de chinoline et de ses dérivés
GB969813A (en) Improvements in or relating to 1,2,4-oxadiazole derivatives
GB1024809A (en) Process for the production of 6-acylamino-penicillanic acids
FR2326194A1 (fr) Phenothiazines carboxamides utilisables dans le traitement des syndromes extra-pyramidaux et de la maladie de parkinson
GB822134A (en) Process for aminating nitrogen-containing heterocyclic compounds
DK2077264T3 (da) Taxanderivater og fremgangsmåde til fremstilling heraf
GB976071A (en) A pigment
FR2309219A1 (fr) Amides acetyleniques possedant une action sur le systeme nerveux central
FR1605008A (en) 3-dialkylaminoalkoxy-indazoles - with antirheumatic activity by two-stage process from 3-hydroxyindazoles